From April 1, 2022 to May 13, 2022, the company has repurchased 36,500 shares, representing 0.08% for ¥69.88 million. With this, the company has completed the repurchase of 755,900 shares, representing 1.68% for ¥1,481.32 million under the buyback announced on November 4, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,961 JPY | +0.05% | -2.00% | -2.78% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.78% | 551M | |
+16.31% | 42.32B | |
+16.32% | 21.29B | |
+19.33% | 15.29B | |
+18.71% | 14.36B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.24% | 6.58B | |
-8.87% | 5.73B | |
+11.64% | 5.51B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2021.